C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI. | MicrobiomeTrials← Back to trialsNCT07250724
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-03-01Est. Completion: 2026-10-15
Enrollment target: 60 participants Locations- Emory University Hospital, Atlanta, Georgia, United States
- Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States
- Mayo Clinic, Minnesota, Rochester, Minnesota, United States
- University of Wisconsin-Madison, Madison, Wisconsin, United States
Other microbiome trials you might be interested in
Leukemia, Lymphocytic, AcuteLeukemia, Myeloid, AcuteLymphomaClostridium Difficile InfectionSolid Cancers
The primary objective of the study is to determine whether dietary intervention to increase fiber and decrease fat reduc…
Aurora, United StatesCompleted Jul 2, 2025
Clostridioides Difficile Infection
The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioid…
Phoenix, United StatesEst. completion Apr 20, 2027
Clostridoides Difficile Associated Disease
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile…
Athens, United StatesEst. completion Dec 11, 2028